หน้าแรก
ค้นหา
Managing Essential Thrombocythemia in 2021 - Dr. Tiziano Barbui
Presented at the 12th Joyce Niblack Memorial Conference on February 19, 2021
แสดงข้อมูลเพิ่มเติม 1
Managing Essential Thrombocythemia in 2021 - Dr. Tiziano Barbui
Essential Thrombocythemia: What Patients Should Know (2022) | Top MPN Specialist Dr. Ruben Mesa
Lower IPSS score associated with higher thrombosis risk in patients with myelofibrosis
Myeloproliferative neoplasms around the COVID-19 pandemic - Professor Tiziano Barbui
Essential Thrombocythemia
Essential Thrombocythemia: A Case Study - Jerry L. Spivak, MD
Management of ET
Patient and disease related risk factors for thrombosis
MPN and COVID 19- What have we learned so far- Prof. Tiziano Barbui, Bergamo, Italy
Current approaches and new approvals in MF and PV
12 Management of thrombocytopenia and bleeding,including recongnition of disseminated intravascular
Case 3: Low- to Intermediate- Risk Essential Thrombocythemia
MPN Molecular Biology - Dr. Jyoti Nangalia
Essential Thrombocythemia EXPLAINED: Pathogenesis, Splenomegaly & Thrombosis (USMLE Guide)
The Genetic Basis of Myeloproliferative Neoplasms and Its Clinical Relevance
Molecular Prognostication in Essential Thrombocythemia and Polycythemia vera: Does it Matter?
Ellen Ritchie, MD-Cardiac Complications and MPN
Conversation with MPN Specialists: Focus on Myelofibrosis
CR&T Virtual Symposium 2020 - Presentations, Part 2
Topical challenges in the management of ET
